What condition can severe pneumonia in infants indicate regarding their treatment?

Severe pneumonia in infants often indicates a need for more specialized treatment, particularly when caused by viral pathogens such as Respiratory Syncytial Virus (RSV). Ribavirin, an antiviral medication, is typically used for treating RSV infections, particularly in high-risk infants. When infants present with severe pneumonia, it suggests a significant respiratory compromise, and using Ribavirin may be warranted in this context to manage the viral infection effectively.

In contrast, over-the-counter medications are generally not suitable for treating severe pneumonia, especially in infants, as their condition often requires more direct and potent intervention. Similarly, while respiratory therapy assistance is often needed in clinical scenarios involving pneumonia, the use of Ribavirin specifically targets the underlying viral cause when it's indicated. Immediate discharge is not typically feasible for those exhibiting severe pneumonia, as they require close monitoring and treatment until their condition stabilizes.